Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000251033 | SCV000313106 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV002328746 | SCV002633969 | uncertain significance | Primary ciliary dyskinesia | 2022-02-17 | criteria provided, single submitter | clinical testing | The p.T157I variant (also known as c.470C>T), located in coding exon 3 of the CCDC40 gene, results from a C to T substitution at nucleotide position 470. The threonine at codon 157 is replaced by isoleucine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |